Literature DB >> 27450156

Optimization of left ventricular pacing site plus multipoint pacing improves remodeling and clinical response to cardiac resynchronization therapy at 1 year.

Francesco Zanon1, Lina Marcantoni2, Enrico Baracca2, Gianni Pastore2, Daniela Lanza3, Chiara Fraccaro3, Claudio Picariello3, Luca Conte3, Silvio Aggio3, Loris Roncon3, Domenico Pacetta4, Nima Badie5, Franco Noventa6, Frits W Prinzen7.   

Abstract

BACKGROUND: Approximately one-third of the patients with heart failure (HF) treated with cardiac resynchronization therapy (CRT) fail to respond. Positioning the left ventricular (LV) pacing lead in the area of the latest electrical delay may improve the response to CRT. Multipoint pacing (MPP) of the LV has been shown to improve the acute hemodynamic response.
OBJECTIVE: The purpose of this study was to test the hypothesis that patients treated with MPP in whom LV pacing location is optimized have better long-term clinical outcomes than do patients treated with conventional CRT.
METHODS: We evaluated the echocardiographic and clinical response of 110 patients with HF treated for nearly 1 year with either conventional CRT (standard [STD] group, n = 54, 49%), CRT with hemodynamic and electrical optimization of the LV pacing site (optimized [OPT] group, n = 36, 33%), or OPT combined with MPP (OPT + MPP group, n = 20, 18%). Responders were classified in terms of reduction in end-systolic volume index ≥15%, reduction in New York Heart Association (NYHA) class ≥1, and Packer score variation (NYHA response with no HF-related hospitalization events or death).
RESULTS: In STD, OPT, and OPT + MPP groups, 56%, 72%, and 90% of patients, respectively, were end-systolic volume index responders (P = .004) and 67%, 78%, and 95% were NYHA class responders (P = .012); 59%, 67%, and 90% of patients exhibited a 1-year Packer score of 0 (P = .018). These trends remained significant after adjustment for confounding factors by multivariate logistic analysis.
CONCLUSION: Combining MPP with optimal positioning of the LV lead on the basis of electrical delay and hemodynamics enhances reverse remodeling and improves clinical outcomes beyond the effect due to conventional CRT.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac resynchronization therapy; Electrical delay; Heart failure; Hemodynamic response; Left ventricular pacing; Multipoint pacing

Mesh:

Year:  2016        PMID: 27450156     DOI: 10.1016/j.hrthm.2016.05.015

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  14 in total

Review 1.  Updates in Cardiac Resynchronization Therapy for Chronic Heart Failure: Review of Multisite Pacing.

Authors:  Antonios P Antoniadis; Ben Sieniewicz; Justin Gould; Bradley Porter; Jessica Webb; Simon Claridge; Jonathan M Behar; Christopher Aldo Rinaldi
Journal:  Curr Heart Fail Rep       Date:  2017-10

Review 2.  Multisite pacing via a quadripolar lead for cardiac resynchronization therapy.

Authors:  Alexandre Bodin; Arnaud Bisson; Clémentine Andre; Bertrand Pierre; Laurent Fauchier; Dominique Babuty; Nicolas Clementy
Journal:  J Interv Card Electrophysiol       Date:  2019-07-18       Impact factor: 1.900

Review 3.  Novel Pacing Strategies for Heart Failure Management.

Authors:  Jordan S Leyton-Mange; Theofanie Mela
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-08

Review 4.  [Multipoint pacing-more CRT or a waste of battery power?]

Authors:  J Müller-Leisse; C Zormpas; T König; D Duncker; C Veltmann
Journal:  Herz       Date:  2018-11       Impact factor: 1.443

5.  Device therapy in heart failure with reduced ejection fraction-cardiac resynchronization therapy and more.

Authors:  D Duncker; C Veltmann
Journal:  Herz       Date:  2018-08       Impact factor: 1.443

6.  Clinical outcome of left ventricular multipoint pacing versus conventional biventricular pacing in cardiac resynchronization therapy: a systematic review and meta-analysis.

Authors:  Feng Hu; Lihui Zheng; Ligang Ding; Zhongpeng Du; Erpeng Liang; Lingmin Wu; Gang Chen; Xiaohan Fan; Yan Yao; Yu Jiang
Journal:  Heart Fail Rev       Date:  2018-11       Impact factor: 4.214

Review 7.  Cardiac resynchronization therapy in heart failure patients: tough road but clear future.

Authors:  Ziyu Wang; Yongquan Wu; Junmeng Zhang
Journal:  Heart Fail Rev       Date:  2020-10-24       Impact factor: 4.214

Review 8.  Advances in Cardiac Resynchronization Therapy.

Authors:  Asif Jafferani; Miguel A Leal
Journal:  J Innov Card Rhythm Manag       Date:  2019-06-15

9.  Hemodynamic comparison of different multisites and multipoint pacing strategies in cardiac resynchronization therapies.

Authors:  Francesco Zanon; Lina Marcantoni; Enrico Baracca; Gianni Pastore; Giuseppina Giau; Gianluca Rigatelli; Daniela Lanza; Claudio Picariello; Silvio Aggio; Sara Giatti; Marco Zuin; Loris Roncon; Domenico Pacetta; Franco Noventa; Frits W Prinzen
Journal:  J Interv Card Electrophysiol       Date:  2018-04-07       Impact factor: 1.900

Review 10.  Cardiac resynchronization therapy in ischemic and non-ischemic cardiomyopathy.

Authors:  Hisashi Yokoshiki; Hirofumi Mitsuyama; Masaya Watanabe; Takeshi Mitsuhashi; Akihiko Shimizu
Journal:  J Arrhythm       Date:  2017-04-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.